Dong Hong Chen

Dong Hong Chen

Chief Tech/Sci/R&D Officer presso OCUMENSION THERAPEUTICS

53 anni
Consumer Services
Health Technology
Distribution Services

Profilo

Dong Hong Chen is currently the Chief Medical Officer at Ocumension Therapeutics since 2019.
Prior to this, she worked as the Head of Clinical Development & Medical Affairs at Alcon Hong Kong Ltd.
from 2016 to 2019, Deputy General Manager-Research & Development at Vanway Pharmaceutical Holdings Ltd.
from 2015 to 2016, and Senior Scientist at GlaxoSmithKline (China) R&D Co., Ltd.
from 2010 to 2013.
She also worked as the Medical Director-Asia Pacific Region at STAAR Surgical Co. from 2013 to 2014.
Dr. Chen received her doctorate degree from Fudan University in 2003, her graduate degree from Nanjing Medical University in 1997, and her undergraduate degree from Yangzhou University in 1991.

Posizioni attive di Dong Hong Chen

SocietàPosizioneInizio
OCUMENSION THERAPEUTICS Chief Tech/Sci/R&D Officer 28/10/2019
Tutte le posizioni attive di Dong Hong Chen

Precedenti posizioni note di Dong Hong Chen

SocietàPosizioneFine
Corporate Officer/Principal 01/10/2019
Chief Tech/Sci/R&D Officer 01/04/2016
STAAR SURGICAL COMPANY Chief Tech/Sci/R&D Officer 01/12/2014
GlaxoSmithKline (China) R&D Co., Ltd. Corporate Officer/Principal 01/01/2013
Vedi nel dettaglio l'esperienza di Dong Hong Chen

Formazione di Dong Hong Chen

Fudan University Doctorate Degree
Yangzhou University Undergraduate Degree
Nanjing Medical University Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Dong Hong Chen

Relazioni

100 +

Relazioni di 1° grado

8

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
STAAR SURGICAL COMPANY

Health Technology

OCUMENSION THERAPEUTICS

Health Technology

Aziende private3

Distribution Services

Health Services

GlaxoSmithKline (China) R&D Co., Ltd.

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Dong Hong Chen